2016 American Transplant Congress

Saturday, June 11, 2016

5:30pm-7:30pm

Endoscopic Polydimethylsiloxane Injection in Prevention of Recurrent Graft Pyelonephritis for Transplanted Kidney with Vesicoureteral Reflux.

L. Nison,¹ M. Hazzan,² P. Puech,³ S. Bouye.¹

Poster Session A: Long Term Outcomes in Kidney Transplantation  •  Halls C&D

5:30pm-7:30pm

Establishing a Learning Curve for Laparoscopic Living Donor Nephrectomy.

Z. Ahmed, R. Tamburrini, R. Uwechue, P. Chandak, F. Calder, N. Kessaris, N. Mamode.

Poster Session A: Kidney Donor Outcomes  •  Halls C&D

5:30pm-7:30pm

Evaluating Associations Between Clinical and Psychosocial Risk Factors and Adverse Post-Transplant Events in High Risk Renal Transplant Recipients.

C. Yellman, D. Destiche, A. DeMers, I. Feurer, M. Via, C. Gamble, H. Schaefer.

Poster Session A: Poster Session III: Kidney Complications-Other  •  Halls C&D

5:30pm-7:30pm

Evaluating Delayed Graft Function After Kidney Transplantation as a Potential Surrogate Outcome.

S. Cramm, X. Luo, A. Massie, D. Segev.

Poster Session A: Long Term Outcomes in Kidney Transplantation  •  Halls C&D

5:30pm-7:30pm

Everolimus Decline Anti-ABO Blood Type Antibody Titer in Desensitization for ABO Incompatible Kidney Transplantation.

Y. Wada, N. Fukuzawa, H. Harada.

Poster Session A: Kidney Desensitization  •  Halls C&D

5:30pm-7:30pm

Evolving to Everolimus: A Safe and Effective Option for Pancreas Transplant.

S. Yeager, A. Carlson, C. Truax, N. Kenyon, F. Ahmed, J. Corbett, F. Shihab, L. Smith.

Poster Session A: Clinical Pancreas Transplantation and All Islet Cell Transplantation Topics  •  Halls C&D

5:30pm-7:30pm

Ex Vivo Expansion of Human Alloantigen-Reactive Regulatory T Cells Using Monocyte-Derived Dendritic Cells versus CD40L-Stimulated B Cells.

H. Zhang,¹ Y. Zhao,¹ L. Lu,¹ Q. Tang,² M. Ezzelarab,¹ A. Thomson.¹

Poster Session A: B cells & AMR, Alloreactivity, Immune Regulation & Regulatory T Cells, T Cell Biology and Alloreactivity, Immunesuppression  •  Halls C&D

5:30pm-7:30pm

Exposure Analysis for the Composite Efficacy Endpoints in the US92 Phase 3 Kidney Transplantation Trial to Understand Center Effects.

F. Shihab, B. Kaplan, K. McCague, D. Patel, F. Vincenti.

Poster Session A: Kidney: Acute Cellular Rejection  •  Halls C&D

5:30pm-7:30pm

Fatigue, Pain, and Other Physical Symptoms of Living Liver Donors.

Z. Butt,¹ A. DiMartini,² Q. Liu,³ M. Simpson,⁴ A. Smith,^3,5 J. Zee,³ B. Gillespie,⁵ S. Holtzman,⁶ D. Ladner,¹ K. Olthoff,⁷ R. Fisher,⁸ S. Hafliger,⁹ C. Freise,¹⁰ M. Mandell,¹¹ M. Dew.²

Poster Session A: Living Donor Liver Transplantation  •  Halls C&D

5:30pm-7:30pm

Fluctuation of Renal Function During the First Year Is Associated with Negative Impact on Long-Term Kidney Graft Survival: A Retrospective, Propensity Score-Matched Study.

H. Choi,¹ D. Joo,^2,3 M. Song,⁴ M. Kim,^2,3 Y. Kim,^2,3 B. Kim.^1,3

Poster Session A: Long Term Outcomes in Kidney Transplantation  •  Halls C&D